Drug profile · INN
raltegravir
ISENTRESS
raltegravir (ISENTRESS) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
EMA: approved TGA: approved Antiinfectives for systemic use (J05) J05AJ01
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — raltegravir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
raltegravir (ISENTRESS) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
Key facts
INN raltegravir
Brand ISENTRESS
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AJ01
Originator Merck KGaA, Darmstadt, Germany
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is raltegravir?
raltegravir (ISENTRESS) is an FDA-listed pharmaceutical active ingredient. Associated with Merck KGaA, Darmstadt, Germany.
What is the brand name for raltegravir?
ISENTRESS is a marketed brand name for raltegravir. Check FDA Drugs@FDA for the current US label holder and prescribing information.